⚠ Research and educational use only — not for human consumption. Nothing for sale, no dosing advice. PeptideCompare is non-profit and independent.
Compare free →
Suppliers 🛡 Quality & badges 📖 Encyclopedia 📰 Articles 🧪 Calculator
LONGEVITY TOPICS
⚡ NAD+ Precursors 🔑 Sirtuin Activators 🧹 Senolytics ♻️ Autophagy 🔋 Mitochondrial 🌡️ Hormesis
About FAQ Contact Policy
Home / Encyclopedia / Growth Hormone Axis / CJC-1295 (DAC) vs CJC-1295 (No DAC)
⚖️ Growth Hormone Axis

CJC-1295 (DAC) vs CJC-1295 (No DAC)

How do CJC-1295 (DAC) and CJC-1295 (No DAC) compare for Growth Hormone Axis research? Side-by-side evidence, molecular profile, EU legal status and COA-verified supplier prices — never dosing advice.

At a glance

CJC-1295 (DAC)

⚡ Growth Hormone Axis
EVIDENCE BASE
SEQUENCE
Modified GHRH(1-29)
MW
~3368 Da
CAS
863288-34-0
EU STATUS
Research only
WADA
Prohibited S2
MIN PURITY
≥98% HPLC
Molecular weight
~3368 Da
CAS number
863288-34-0
Route
Subcutaneous (weekly)
Half-life (t½)
≈6–8 days
PRICE FROM
€44.05 · 4 EU vendors
View prices →

CJC-1295 (No DAC)

⚡ Growth Hormone Axis
EVIDENCE BASE
CLASS
GHRH analog
HALF-LIFE
~30 min
CAS
863288-34-0
ALSO KNOWN AS
Modified GRF(1-29)
EU STATUS
Research only
WADA
Prohibited S2
Molecular weight
3367.9 g/mol
CAS number
863288-34-0
Route
Subcutaneous
Half-life (t½)
≈30 min
PRICE FROM
€23.89 · 7 EU vendors
View prices →

Which fits which research target?

Both CJC-1295 (DAC) and CJC-1295 (No DAC) sit within Growth Hormone Axis research but are studied for different primary signals. Neither is an approved medicine — compare the evidence, not marketing claims.

PRIMARY RESEARCH SIGNAL
CJC-1295 (DAC)
Sustained GH / IGF-1 elevation
CJC-1295 (No DAC)
Pulsatile GH release
Neither CJC-1295 (DAC) nor CJC-1295 (No DAC) is an approved medicine. All comparisons here are research observations, not usage, dosing or efficacy recommendations.

What the research shows

CJC-1295 (DAC)

EVIDENCE SUMMARY
MODERATE
Sustained GH / IGF-1 elevation — Albumin-binding DAC extends half-life to days; early human data show sustained GH and IGF-1 increases.
LIMITED
Body composition — Effects on fat and lean mass are inferred from GH elevation; direct clinical trials are limited.

CJC-1295 (No DAC)

EVIDENCE SUMMARY
MODERATE
Pulsatile GH release — GHRH-receptor stimulation producing short, physiological GH pulses; a well-established mechanism.
LIMITED
Clinical outcome data — Most human data derive from the parent GRF(1-29)/sermorelin; direct trials of the modified peptide are limited.

Compare prices across EU suppliers

Compare CJC-1295 (DAC) across EU suppliers

4 EU vendors · COA · from €44.05

View prices →

Compare CJC-1295 (No DAC) across EU suppliers

7 EU vendors · COA · from €23.89

View prices →

Frequently asked questions

Is CJC-1295 (DAC) or CJC-1295 (No DAC) better?

Neither is an approved medicine, and “better” depends on the research target. CJC-1295 (DAC) is most associated with Sustained GH / IGF-1 elevation, while CJC-1295 (No DAC) is studied for Pulsatile GH release. Compare the evidence tiers and COA-verified EU pricing above rather than assuming one is superior. This is not a usage recommendation.

Why compare CJC-1295 (DAC) and CJC-1295 (No DAC)?

Both are studied within Growth Hormone Axis research through different mechanisms, so researchers often weigh them against each other. This page sets their evidence, molecular profile, EU legal status and supplier pricing side by side.

Which is cheaper in the EU, CJC-1295 (DAC) or CJC-1295 (No DAC)?

Prices vary by supplier, vial size and COA status. CJC-1295 (DAC) is listed from €44.05 across 4 COA-verified EU vendors; CJC-1295 (No DAC) from €23.89 across 7. Open the price pages above to compare current listings — nobody pays us for placement.

Read the full guides

PeptideCompare AssistantOnline · replies instantly
Hi! I help you quickly find the right page — about legality, COAs, badges or suppliers. No price advice, no dosing.
Try a question
What does COA Verified mean? Most tested supplier? Is this legal here?
Navigation assistant · no medical advice